• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A-56268(TE-031)对革兰氏阳性菌、革兰氏阴性菌及沙眼衣原体的体外活性比较

Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.

作者信息

Benson C, Segreti J, Kessler H, Hines D, Goodman L, Kaplan R, Trenholme G

出版信息

Eur J Clin Microbiol. 1987 Apr;6(2):173-8. doi: 10.1007/BF02018203.

DOI:10.1007/BF02018203
PMID:2954818
Abstract

The in vitro activity of A-56268 (TE-031) was determined and compared with that of 13 antibiotics against 401 gram-positive and gram-negative bacteria and 11 strains of Chlamydia trachomatis. A-56268 was very active against methicillin-susceptible Staphylococcus aureus and Neisseria gonorrhoeae, and was among the most active of the agents tested against Listeria monocytogenes, streptococci and Chlamydia trachomatis. It was moderately active against Haemophilus spp., Vibrio spp., Campylobacter jejuni and Campylobacter fetus subsp. fetus. It was inactive against enterococci, methicillin-resistant Staphylococcus aureus, Staphylococcus epidermidis, Campylobacter coli, Salmonella spp., Shigella spp. and Yersinia enterocolitica. A-56268 was not consistently bactericidal or more active than erythromycin for any organism except Chlamydia trachomatis.

摘要

测定了A-56268(TE-031)的体外活性,并将其与13种抗生素针对401株革兰氏阳性菌和革兰氏阴性菌以及11株沙眼衣原体的活性进行了比较。A-56268对甲氧西林敏感金黄色葡萄球菌和淋病奈瑟菌具有很强的活性,并且是针对单核细胞增生李斯特菌、链球菌和沙眼衣原体测试的药物中活性最强的之一。它对嗜血杆菌属、弧菌属、空肠弯曲菌和胎儿弯曲菌胎儿亚种具有中等活性。它对肠球菌、耐甲氧西林金黄色葡萄球菌、表皮葡萄球菌、结肠弯曲菌、沙门氏菌属、志贺氏菌属和小肠结肠炎耶尔森菌无活性。除沙眼衣原体外,A-56268对任何生物体都没有持续的杀菌作用,也不比红霉素更具活性。

相似文献

1
Comparative in vitro activity of A-56268 (TE-031) against gram-positive and gram-negative bacteria and Chlamydia trachomatis.A-56268(TE-031)对革兰氏阳性菌、革兰氏阴性菌及沙眼衣原体的体外活性比较
Eur J Clin Microbiol. 1987 Apr;6(2):173-8. doi: 10.1007/BF02018203.
2
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms.新型大环内酯类药物A-56268(TE-031)与红霉素和克林霉素相比,对所选革兰氏阳性菌和革兰氏阴性菌的体外活性。
Antimicrob Agents Chemother. 1987 Feb;31(2):328-30. doi: 10.1128/AAC.31.2.328.
3
Comparative in vitro activity of clarithromycin. Spanish Collaborative Group.克拉霉素的体外活性比较。西班牙协作组。
Eur J Clin Microbiol Infect Dis. 1992 Sep;11(9):856-66. doi: 10.1007/BF01960892.
4
Comparative in vitro activity of the new erythromycin derivative dirithromycin against gram-positive bacteria isolated from cancer patients.新型红霉素衍生物地红霉素对从癌症患者中分离出的革兰氏阳性菌的体外比较活性
Eur J Clin Microbiol Infect Dis. 1990 Jan;9(1):30-3. doi: 10.1007/BF01969529.
5
Comparative in-vitro activity of A-56268 (TE-031), a new macrolide antibiotic.新型大环内酯类抗生素A-56268(TE-031)的体外活性比较
J Antimicrob Chemother. 1987 Nov;20(5):671-5. doi: 10.1093/jac/20.5.671.
6
Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates.氧氟沙星和环丙沙星对某些选定革兰氏阳性菌和革兰氏阴性菌分离株的体外抗菌活性比较
Infection. 1986;14 Suppl 4:S237-9. doi: 10.1007/BF01661280.
7
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.Ro 15 - 8074、Ro 19 - 5247、A - 56268及罗红霉素(RU 28965)对淋病奈瑟菌和沙眼衣原体的体外活性。
Antimicrob Agents Chemother. 1987 Mar;31(3):470-2. doi: 10.1128/AAC.31.3.470.
8
CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.CEM-101,一种新型氟酮内酯:对多种革兰氏阳性菌和革兰氏阴性菌的抗菌活性。
Diagn Microbiol Infect Dis. 2010 Apr;66(4):393-401. doi: 10.1016/j.diagmicrobio.2009.10.013.
9
[Azithromycin: critical points].[阿奇霉素:关键点]
Pathol Biol (Paris). 1995 Jun;43(6):488-97.
10
Antibacterial activity of rokitamycin compared with that of other macrolides.与其他大环内酯类药物相比,罗他霉素的抗菌活性
Diagn Microbiol Infect Dis. 1991 Jul-Aug;14(4):331-5. doi: 10.1016/0732-8893(91)90024-a.

引用本文的文献

1
Ancillary benefits of Mycobacterium avium-intracellulare complex prophylaxis with clarithromycin in HIV-infected patients.在HIV感染患者中使用克拉霉素预防鸟分枝杆菌复合群的辅助益处。
Drugs. 1997;54 Suppl 2:16-22; discussion 28-9. doi: 10.2165/00003495-199700542-00005.
2
Clarithromycin clinical pharmacokinetics.克拉霉素的临床药代动力学。
Clin Pharmacokinet. 1993 Sep;25(3):189-204. doi: 10.2165/00003088-199325030-00003.
3
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

本文引用的文献

1
Successful use of broth microdilution in susceptibility tests for methicillin-resistant (heteroresistant) staphylococci.肉汤微量稀释法在耐甲氧西林(异质性耐药)葡萄球菌药敏试验中的成功应用。
J Clin Microbiol. 1983 Nov;18(5):1084-91. doi: 10.1128/jcm.18.5.1084-1091.1983.
2
Antibacterial activity of Ro 17-2301 and other antimicrobial agents against cefotaxime-resistant aerobic gram-negative bacilli.Ro 17-2301及其他抗菌剂对耐头孢噻肟需氧革兰氏阴性杆菌的抗菌活性。
Antimicrob Agents Chemother. 1986 Jan;29(1):155-7. doi: 10.1128/AAC.29.1.155.
3
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis.
克拉霉素:抗菌活性、药代动力学特性及治疗潜力综述
Drugs. 1992 Jul;44(1):117-64. doi: 10.2165/00003495-199244010-00009.
A-56268(TE-031)及其他四种抗菌剂对沙眼衣原体的体外活性
Antimicrob Agents Chemother. 1987 Jan;31(1):100-1. doi: 10.1128/AAC.31.1.100.